Psilocybin for depression

BMJ. 2024 May 1:385:q798. doi: 10.1136/bmj.q798.

Authors

Riccardo De Giorgi^{1

2}, Roger Ede^{2

3}

Affiliations

¹ Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX3 7JX, UK riccardo.degiorgi@psych.ox.ac.uk.
² Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.
³ Patient and public representative, Oxford, UK.

PMID: 38692675
DOI: 10.1136/bmj.q798

No abstract available

Publication types

Editorial
Comment

MeSH terms

Depressive Disorder / drug therapy
Hallucinogens* / therapeutic use
Humans
Psilocybin* / therapeutic use

Substances

Psilocybin
Hallucinogens